Asthma - Market Insights, Epidemiology and Market Forecast-2023

Publisher Name :
Date: 01-Jan-2017
No. of pages: 100
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's Asthma - Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Crohn's disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Asthma forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Asthma till 2023.

Key Coverage and Benefits

  • The report will help in developing business strategies by understanding the trends shaping and driving the global Asthma market.

  • Identifying patient populations in the global "Asthmamarket to improve product design, pricing, and launch plans.

  • Organize sales and marketing efforts by identifying the best opportunities for Asthma therapeutics in each of the markets covered.

  • To understand the future market competition in the global Asthma therapeutics market and Insightful review of the key market drivers and barriers.

Scope

  • Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.

  • Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.

  • The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.

  • It also provides Asthma for United States, EU5 and Japan from 2013 and forecasted Market to 2023.

Asthma - Market Insights, Epidemiology and Market Forecast-2023

Table of Contents

Table of
Asthma overview
Pathophysiology
Symptoms of disease
Etiology of disease
Diagnosis of disease
Treatment of disease
Overview of Marketed drugs
Drug Description
Mechanism of Action
Pharmacokinetics Properties
Marketed Details
Patent Information
Patent Exclusivity Expiry Assessment United States (US)
Patents Details
Historical and Forecasted sales of marketed molecules in the Global Asthma Market
Global Epidemiology of Asthma Forecasted to 2023
Global Market (2013-2015)
Global Forecasted Market (2016-2023)
Global Market by Geography
Market of US (2013-2015)
Forecasted Market of US (2016-2023)
Market of Europe
Market of Germany (2013-2015)
Forecasted Market of Germany (2016-2023)
Market of United Kingdom (2013-2015)
Forecasted Market of United Kingdom (2016-2023)
Market of France (2013-2015)
Forecasted Market of France (2016-2023)
Market of Italy (2013-2015)
Forecasted Market of Italy (2016-2023)
Market of Spain (2013-2015)
Forecasted Market of Spain (2016-2023)
Market of Japan (2013-2015)
Forecasted Market of Japan (2016-2023)
Market of ROW (2013-2015)
Forecasted Market of ROW (2016-2023)
Appendix
Report Methodology
Consulting Services
Disclaimer
Report Purchase Options
About DelveInsight

List of Tables

Table 1: Drug Description
Table 2: Drug, Marketed Details United States (US)
Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
Table 4: Drug, Patent Details for US
Table 5: Asthma Drug Sales (USD Millions)-2023
Table 6: Global Epidemiology of Asthma (2013-2023)
Table 7: Asthma Global Market (USD Millions), (2013-2015)
Table 8: Asthma Global Market (USD Millions), (2016-2023)
Table 9: Asthma US Market (USD Millions), (2013-2015)
Table 10: Asthma US Market (USD Millions), (2016-2023)
Table 11: Asthma Germany Market (USD Millions), (2013-2015)
Table 12: Asthma Germany Market (USD Millions), (2016-2023)
Table 13: Asthma United Kingdom Market (USD Millions), (2013-2015)
Table 14: Asthma United Kingdom Market (USD Millions), (2016-2023)
Table 15: Asthma France Market (USD Millions), (2013-2015)
Table 16: Asthma France Market (USD Millions), (2016-2023)
Table 17: Asthma Italy Market (USD Millions), (2013-2015)
Table 18: Asthma Italy Market (USD Millions), (2016-2023)
Table 19: Asthma Spain Market (USD Millions), (2013-2015)
Table 20: Asthma Spain Market (USD Millions), (2016-2023)
Table 21: Asthma Japan Market (USD Millions), (2013-2015)
Table 22: Asthma Japan Market (USD Millions), (2016-2023)
Table 23: Asthma ROW Market (USD Millions), (2013-2015)
Table 24: Asthma ROW Market (USD Millions), (2016-2023)

List of Figures

Figure 1: Asthma Drug Sales (USD Millions)-2023
Figure 2: Global Epidemiology of Asthma (2013-2023)
Figure 3: Asthma Global Market (USD Millions), (2013-2015)
Figure 4: Asthma Global Market (USD Millions), (2016-2023)
Figure 5: Asthma US Market (USD Millions), (2013-2015)
Figure 6: Asthma US Market (USD Millions), (2016-2023)
Figure 7: Asthma Germany Market (USD Millions), (2013-2015)
Figure 8: Asthma Germany Market (USD Millions), (2016-2023)
Figure 9: Asthma United Kingdom Market (USD Millions), (2013-2015)
Figure 10: Asthma United Kingdom Market (USD Millions), (2016-2023)
Figure 11: Asthma France Market (USD Millions), (2013-2015)
Figure 12: Asthma France Market (USD Millions), (2016-2023)
Figure 13: Asthma Italy Market (USD Millions), (2013-2015)
Figure 14: Asthma Italy Market (USD Millions), (2016-2023)
Figure 15: Asthma Spain Market (USD Millions), (2013-2015)
Figure 16: Asthma Spain Market (USD Millions), (2016-2023)
Figure 17: Asthma Japan Market (USD Millions), (2013-2015)
Figure 18: Asthma Japan Market (USD Millions), (2015-2023)
Figure 19: Asthma ROW Market (USD Millions), (2013-2015)
Figure 20: Asthma ROW Market (USD Millions), (2016-2023)

  • Asthma - Epidemiology Forecast To 2023
    Published: 01-Jan-2017        Price: US 2750 Onwards        Pages: 60
    DelveInsight "Asthma - Epidemiology Forecast To 2023" provides an overview of the epidemiology trends of Asthma in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Asthma prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Asthma. The report is built usi......
  • Chronic Asthma-Pipeline Insights, 2017
    Published: 01-Jan-2017        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, " Chronic Asthma-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Chronic Asthma. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions,......
  • Singulair Paediatric -Drug Insights, 2017
    Published: 01-Jan-2017        Price: US 1000 Onwards        Pages: 35
    DelveInsight Drug Report, "Singulair Paediatric- Drug Insights, 2017" highlights the Singulair Paediatric marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight's report covers the Global Market Assessment of the Singulair Paediatric covering the total sales estimation and also provides the Singulair Paediatric sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical a......
  • Asthma-API Insights, 2017
    Published: 01-Jan-2017        Price: US 1250 Onwards        Pages: 60
    The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have......
  • Vannair -Drug Insights, 2017
    Published: 01-Jan-2017        Price: US 1000 Onwards        Pages: 35
    DelveInsight Drug Report, "Vannair- Drug Insights, 2017" highlights the Vannair marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight's report covers the Global Market Assessment of the Vannair covering the total sales estimation and also provides the Vannair sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Vannair, patents information and exclus......
  • Chronic Asthma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Jan-2017        Price: US 2000 Onwards        Pages: 100
    DelveInsight's Report, "Chronic Asthma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Chronic Asthma Report is to understand the market and pipeline status of the drugs around the Chronic Asthma to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on desi......
  • Xolair -Drug Insights, 2017
    Published: 01-Jan-2017        Price: US 1000 Onwards        Pages: 35
    DelveInsight Drug Report, "Xolair- Drug Insights, 2017" highlights the Xolair marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight's report covers the Global Market Assessment of the Xolair covering the total sales estimation and also provides the Xolair sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Xolair, patents information and exclusivity......
  • Zenhale -Drug Insights, 2017
    Published: 01-Jan-2017        Price: US 1000 Onwards        Pages: 35
    DelveInsight Drug Report, "Zenhale- Drug Insights, 2017" highlights the Zenhale marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight's report covers the Global Market Assessment of the Zenhale covering the total sales estimation and also provides the Zenhale sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Zenhale, patents information and exclus......
  • Asthma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Jan-2017        Price: US 2000 Onwards        Pages: 100
    DelveInsight's Report, "Asthma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Asthma Report is to understand the market and pipeline status of the drugs around the Asthma to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegie......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs